Bright Rock Capital Management’s Edwards Lifesciences EW Stock Holding History

Bright Rock Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.26M	Hold	25,000	–	–	0.45%	56
2026 Q1	$2M	Hold	25,000	–	–	0.4%	61
2025 Q4	$2.13M	Hold	25,000	–	–	0.42%	62
2025 Q3	$1.94M	Hold	25,000	–	–	0.38%	64
2025 Q2	$1.96M	Hold	25,000	–	–	0.4%	64
2025 Q1	$1.81M	Hold	25,000	–	–	0.38%	66
2024 Q4	$1.85M	Hold	25,000	–	–	0.39%	60
2024 Q3	$1.65M	Hold	25,000	–	–	0.33%	67
2024 Q2	$2.31M	Hold	25,000	–	–	0.49%	58
2024 Q1	$2.39M	Hold	25,000	–	–	0.5%	56
2023 Q4	$1.91M	Hold	25,000	–	–	0.43%	60
2023 Q3	$1.73M	Hold	25,000	–	–	0.42%	60
2023 Q2	$2.36M	Hold	25,000	–	–	0.55%	56
2023 Q1	$2.07M	Hold	25,000	–	–	0.52%	55
2022 Q4	$1.86M	Hold	25,000	–	–	0.48%	59
2022 Q3	$2.07M	Hold	25,000	–	–	0.58%	57
2022 Q2	$2.38M	Hold	25,000	–	–	0.64%	51
2022 Q1	$2.94M	Hold	25,000	–	–	0.69%	46
2021 Q4	$3.24M	Hold	25,000	–	–	0.74%	50
2021 Q3	$2.83M	Hold	25,000	–	–	0.71%	48
2021 Q2	$2.59M	Hold	25,000	–	–	0.62%	54
2021 Q1	$2.09M	Hold	25,000	–	–	0.53%	60
2020 Q4	$2.28M	Sell	25,000 -14,000	-36%	-$1.16M	0.62%	58
2020 Q3	$3.11M	Hold	39,000	–	–	0.92%	44
2020 Q2	$2.69M	Hold	39,000	–	–	0.84%	44
2020 Q1	$2.45M	Hold	39,000	–	–	0.89%	46
2019 Q4	$3.03M	Hold	39,000	–	–	0.89%	42
2019 Q3	$2.9M	Hold	39,000	–	–	0.91%	42
2019 Q2	$2.4M	Hold	39,000	–	–	0.77%	45
2019 Q1	$2.49M	Hold	39,000	–	–	0.83%	45
2018 Q4	$1.99M	Hold	39,000	–	–	0.75%	46
2018 Q3	$2.26M	Hold	39,000	–	–	0.74%	46
2018 Q2	$1.89M	Hold	39,000	–	–	0.65%	48
2018 Q1	$1.81M	Sell	39,000 -3,000	-7%	-$130K	0.62%	51
2017 Q4	$1.58M	Hold	42,000	–	–	0.43%	73
2017 Q3	$1.53M	Hold	42,000	–	–	0.44%	69
2017 Q2	$1.66M	Hold	42,000	–	–	0.49%	59
2017 Q1	$1.32M	Hold	42,000	–	–	0.39%	79
2016 Q4	$1.31M	Hold	42,000	–	–	0.41%	75
2016 Q3	$1.69M	Hold	42,000	–	–	0.53%	59
2016 Q2	$1.4M	Hold	42,000	–	–	0.45%	60
2016 Q1	$1.24M	Hold	42,000	–	–	0.42%	64
2015 Q4	$1.11M	Hold	42,000	–	–	0.41%	75
2015 Q3	$995K	Hold	42,000	–	–	0.4%	74
2015 Q2	$997K	Hold	42,000	–	–	0.37%	81
2015 Q1	$997K	Hold	42,000	–	–	0.37%	82
2014 Q4	$892K	Hold	42,000	–	–	0.35%	79
2014 Q3	$715K	Hold	42,000	–	–	0.31%	84
2014 Q2	$601K	Hold	42,000	–	–	0.28%	75
2014 Q1	$519K	Hold	42,000	–	–	0.26%	72
2013 Q4	$460K	Hold	42,000	–	–	0.24%	74
2013 Q3	$487K	Buy	+42,000	New	+$491K	0.27%	71

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bright Rock Capital Management's EW Position: Q2 2026 in Review

Bright Rock Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 25,000 shares worth $2.26M. The position accounts for 0.45% of the portfolio, ranked #56.

Bright Rock Capital Management first reported a position in EW in Q3 2013 and has held it in 52 quarters since. The position peaked at $3.24M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Bright Rock Capital Management held 25,000 shares of Edwards Lifesciences worth $2.26M as of Q2 2026.
Bright Rock Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.45% of Bright Rock Capital Management's portfolio in Q2 2026, its #56 holding.
Bright Rock Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 52 quarters since.
Bright Rock Capital Management's Edwards Lifesciences position peaked at $3.24M in Q4 2021.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bright Rock Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.